Terms: = Lymphoma AND STK11, LKB1, 6794, ENSG00000118046, Q15831, PJS
37 results:
1. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/lkb1/AMPK Signalling.
O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
[TBL] [Abstract] [Full Text] [Related]
2. lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape.
Su X; Sun T; Li M; Xia Y; Li M; Wang D; Lu F; Ye J; Ji C
J Transl Med; 2022 Aug; 20(1):378. PubMed ID: 35986288
[TBL] [Abstract] [Full Text] [Related]
3. Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cortellini A; Ricciuti B; Borghaei H; Naqash AR; D'Alessio A; Fulgenzi CAM; Addeo A; Banna GL; Pinato DJ
Cancer; 2022 Aug; 128(16):3067-3079. PubMed ID: 35727053
[TBL] [Abstract] [Full Text] [Related]
4. Biology of primary breast cancer in older women beyond routine biomarkers.
Parks RM; Alfarsi LH; Green AR; Cheung KL
Breast Cancer; 2021 Sep; 28(5):991-1001. PubMed ID: 34165702
[TBL] [Abstract] [Full Text] [Related]
5. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Dudnik E; Moskovitz M; Rottenberg Y; Lobachov A; Mandelboim R; Shochat T; Urban D; Wollner M; Nechushtan H; Rotem O; Zer A; Daher S; Bar J;
Oncoimmunology; 2021 Jan; 10(1):1865653. PubMed ID: 33552685
[TBL] [Abstract] [Full Text] [Related]
6. Repression of lkb1 by
Izreig S; Gariepy A; Kaymak I; Bridges HR; Donayo AO; Bridon G; DeCamp LM; Kitchen-Goosen SM; Avizonis D; Sheldon RD; Laister RC; Minden MD; Johnson NA; Duchaine TF; Rudoltz MS; Yoo S; Pollak MN; Williams KS; Jones RG
Cell Rep Med; 2020 May; 1(2):100014. PubMed ID: 32478334
[TBL] [Abstract] [Full Text] [Related]
7. [Expression Level of lkb1 Gene in Patients with Acute Lymphoblastic Leukemia and Its Correlation with Illness Condition].
Han F; Lai TW; Li H; Tan WM; Wu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):464-469. PubMed ID: 32319380
[TBL] [Abstract] [Full Text] [Related]
8. [Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma].
Liang Y; Hou H; Jiang M; Zhang C; Liu D; Zhang X
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):239-246. PubMed ID: 32316711
[TBL] [Abstract] [Full Text] [Related]
9. p53-mediated control of aspartate-asparagine homeostasis dictates lkb1 activity and modulates cell survival.
Deng L; Yao P; Li L; Ji F; Zhao S; Xu C; Lan X; Jiang P
Nat Commun; 2020 Apr; 11(1):1755. PubMed ID: 32273511
[TBL] [Abstract] [Full Text] [Related]
10. Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell lymphoma.
Bresin A; Cristofoletti C; Caprini E; Cantonetti M; Monopoli A; Russo G; Narducci MG
J Invest Dermatol; 2020 May; 140(5):1045-1053.e6. PubMed ID: 31682844
[TBL] [Abstract] [Full Text] [Related]
11. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy.
Skoulidis F; Heymach JV
Nat Rev Cancer; 2019 Sep; 19(9):495-509. PubMed ID: 31406302
[TBL] [Abstract] [Full Text] [Related]
12. Clonal evolution of chronic lymphocytic leukemia to Langerhans cell histiocytosis: a case report.
Frauenfeld L; Bonzheim I; Wirths S; Steinhilber J; Horger M; Mankel B; Bethge W; Fend F; Federmann B
Virchows Arch; 2019 Dec; 475(6):795-798. PubMed ID: 31317311
[TBL] [Abstract] [Full Text] [Related]
13. Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevance.
Cristofoletti C; Bresin A; Picozza M; Picchio MC; Monzo F; Helmer Citterich M; Passarelli F; Frezzolini A; Scala E; Monopoli A; Cantonetti M; Benucci R; D'Atri S; Caprini E; Russo G; Narducci MG
Leukemia; 2019 May; 33(5):1231-1242. PubMed ID: 30518812
[TBL] [Abstract] [Full Text] [Related]
14. Diagnostic and Predictive Immunohistochemistry for Non-Small Cell Lung Carcinomas.
Hung YP; Sholl LM
Adv Anat Pathol; 2018 Nov; 25(6):374-386. PubMed ID: 30188361
[TBL] [Abstract] [Full Text] [Related]
15. Impact of earlier versus later monitoring on disease progression and healthcare costs among patients with chronic myeloid leukemia in the United States.
Jabbour EJ; Siegartel LR; Lin J; Lingohr-Smith M; Menges B; Makenbaeva D
Leuk Lymphoma; 2019 Mar; 60(3):668-674. PubMed ID: 30124372
[TBL] [Abstract] [Full Text] [Related]
16. Cinacalcet-mediated activation of the CaMKKβ-lkb1-AMPK pathway attenuates diabetic nephropathy in db/db mice by modulation of apoptosis and autophagy.
Lim JH; Kim HW; Kim MY; Kim TW; Kim EN; Kim Y; Chung S; Kim YS; Choi BS; Kim YS; Chang YS; Kim HW; Park CW
Cell Death Dis; 2018 Feb; 9(3):270. PubMed ID: 29449563
[TBL] [Abstract] [Full Text] [Related]
17. Coexistent genetic alterations involving ALK, RET, ROS1 or MET in 15 cases of lung adenocarcinoma.
Tang Z; Zhang J; Lu X; Wang W; Chen H; Robinson MK; Cheng J; Tang G; Medeiros LJ
Mod Pathol; 2018 Feb; 31(2):307-312. PubMed ID: 28914263
[TBL] [Abstract] [Full Text] [Related]
18. lkb1 deletion in murine B lymphocytes promotes cell death and cancer.
Souroullas GP; Fedoriw Y; Staudt LM; Sharpless NE
Exp Hematol; 2017 Jul; 51():63-70.e1. PubMed ID: 28435024
[TBL] [Abstract] [Full Text] [Related]
19. The miR-17∼92 microRNA Cluster Is a Global Regulator of Tumor Metabolism.
Izreig S; Samborska B; Johnson RM; Sergushichev A; Ma EH; Lussier C; Loginicheva E; Donayo AO; Poffenberger MC; Sagan SM; Vincent EE; Artyomov MN; Duchaine TF; Jones RG
Cell Rep; 2016 Aug; 16(7):1915-28. PubMed ID: 27498867
[TBL] [Abstract] [Full Text] [Related]
20. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract] [Full Text] [Related]
[Next]